vs
怪兽饮料（MNST）与SELECT MEDICAL HOLDINGS CORP（SEM）财务数据对比。点击上方公司名可切换其他公司
怪兽饮料的季度营收约是SELECT MEDICAL HOLDINGS CORP的1.5倍（$2.1B vs $1.4B），怪兽饮料净利率更高（21.1% vs 1.4%，领先19.6%），怪兽饮料同比增速更快（17.6% vs 6.4%），怪兽饮料自由现金流更多（$351.2M vs $5.2M），过去两年怪兽饮料的营收复合增速更高（5.9% vs 2.8%）
怪兽饮料是美国知名饮品企业，旗下拥有魔爪、Relentless、Reign、Burn等多款畅销能量饮料产品。公司1935年创立于美国南加州，前身为Hansen's，最初主营果汁产品，2012年正式更为现名。
Select Medical是总部位于美国宾夕法尼亚州的医疗健康企业，业务涵盖长期急症护理、住院康复医院运营，同时开设有职业健康与物理治疗诊所，母公司Select Medical Holdings在纽约证券交易所挂牌上市。
MNST vs SEM — 直观对比
营收规模更大
MNST
是对方的1.5倍
$1.4B
营收增速更快
MNST
高出11.2%
6.4%
净利率更高
MNST
高出19.6%
1.4%
自由现金流更多
MNST
多$346.0M
$5.2M
两年增速更快
MNST
近两年复合增速
2.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.1B | $1.4B |
| 净利润 | $449.2M | $20.2M |
| 毛利率 | 55.5% | — |
| 营业利润率 | 25.5% | 4.6% |
| 净利率 | 21.1% | 1.4% |
| 营收同比 | 17.6% | 6.4% |
| 净利润同比 | 65.9% | 225.7% |
| 每股收益（稀释后） | — | $0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MNSTSEM
| Q4 25 | $2.1B | $1.4B | ||
| Q3 25 | $2.2B | $1.4B | ||
| Q2 25 | $2.1B | $1.3B | ||
| Q1 25 | $1.9B | $1.4B | ||
| Q4 24 | $1.8B | $1.3B | ||
| Q3 24 | $1.9B | $1.3B | ||
| Q2 24 | $1.9B | $1.3B | ||
| Q1 24 | $1.9B | $1.3B |
净利润MNSTSEM
| Q4 25 | $449.2M | $20.2M | ||
| Q3 25 | $524.5M | $28.8M | ||
| Q2 25 | $488.8M | $40.6M | ||
| Q1 25 | $443.0M | $56.7M | ||
| Q4 24 | $270.7M | $-16.1M | ||
| Q3 24 | $370.9M | $55.6M | ||
| Q2 24 | $425.4M | $77.6M | ||
| Q1 24 | $442.0M | $96.9M |
毛利率MNSTSEM
| Q4 25 | 55.5% | — | ||
| Q3 25 | 55.7% | — | ||
| Q2 25 | 55.7% | — | ||
| Q1 25 | 56.5% | — | ||
| Q4 24 | 55.3% | — | ||
| Q3 24 | 53.2% | — | ||
| Q2 24 | 53.6% | — | ||
| Q1 24 | 54.1% | — |
营业利润率MNSTSEM
| Q4 25 | 25.5% | 4.6% | ||
| Q3 25 | 30.7% | 5.4% | ||
| Q2 25 | 29.9% | 6.5% | ||
| Q1 25 | 30.7% | 8.3% | ||
| Q4 24 | 21.0% | 1.6% | ||
| Q3 24 | 25.5% | 4.3% | ||
| Q2 24 | 27.7% | 5.8% | ||
| Q1 24 | 28.5% | 9.0% |
净利率MNSTSEM
| Q4 25 | 21.1% | 1.4% | ||
| Q3 25 | 23.9% | 2.1% | ||
| Q2 25 | 23.1% | 3.0% | ||
| Q1 25 | 23.9% | 4.2% | ||
| Q4 24 | 14.9% | -1.2% | ||
| Q3 24 | 19.7% | 4.4% | ||
| Q2 24 | 22.4% | 6.1% | ||
| Q1 24 | 23.3% | 7.3% |
每股收益（稀释后）MNSTSEM
| Q4 25 | — | $0.17 | ||
| Q3 25 | — | $0.23 | ||
| Q2 25 | — | $0.32 | ||
| Q1 25 | — | $0.44 | ||
| Q4 24 | — | $-0.12 | ||
| Q3 24 | — | $0.43 | ||
| Q2 24 | — | $0.60 | ||
| Q1 24 | — | $0.75 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.8B | $26.5M |
| 总债务越低越好 | — | $1.8B |
| 股东权益账面价值 | $8.3B | $1.7B |
| 总资产 | $10.0B | $5.9B |
| 负债/权益比越低杠杆越低 | — | 1.06× |
8季度趋势，按日历期对齐
现金及短期投资MNSTSEM
| Q4 25 | $2.8B | $26.5M | ||
| Q3 25 | $2.6B | $60.1M | ||
| Q2 25 | $2.1B | $52.3M | ||
| Q1 25 | $1.9B | $53.2M | ||
| Q4 24 | $1.5B | $59.7M | ||
| Q3 24 | $1.6B | $191.5M | ||
| Q2 24 | $1.6B | $111.2M | ||
| Q1 24 | $3.6B | $92.6M |
总债务MNSTSEM
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | $199.1M | $1.8B | ||
| Q4 24 | $374.0M | $1.7B | ||
| Q3 24 | $748.8M | $3.1B | ||
| Q2 24 | $748.7M | $3.6B | ||
| Q1 24 | — | $3.8B |
股东权益MNSTSEM
| Q4 25 | $8.3B | $1.7B | ||
| Q3 25 | $7.7B | $1.7B | ||
| Q2 25 | $7.2B | $1.7B | ||
| Q1 25 | $6.5B | $1.7B | ||
| Q4 24 | $6.0B | $1.7B | ||
| Q3 24 | $5.8B | $1.9B | ||
| Q2 24 | $5.9B | $1.4B | ||
| Q1 24 | $8.6B | $1.4B |
总资产MNSTSEM
| Q4 25 | $10.0B | $5.9B | ||
| Q3 25 | $9.6B | $5.7B | ||
| Q2 25 | $8.7B | $5.7B | ||
| Q1 25 | $8.2B | $5.7B | ||
| Q4 24 | $7.7B | $5.6B | ||
| Q3 24 | $8.1B | $8.0B | ||
| Q2 24 | $8.1B | $7.9B | ||
| Q1 24 | $10.1B | $7.9B |
负债/权益比MNSTSEM
| Q4 25 | — | 1.06× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | 0.03× | 1.03× | ||
| Q4 24 | 0.06× | 1.01× | ||
| Q3 24 | 0.13× | 1.62× | ||
| Q2 24 | 0.13× | 2.54× | ||
| Q1 24 | — | 2.75× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $379.4M | $64.3M |
| 自由现金流经营现金流 - 资本支出 | $351.2M | $5.2M |
| 自由现金流率自由现金流/营收 | 16.5% | 0.4% |
| 资本支出强度资本支出/营收 | 1.3% | 4.2% |
| 现金转化率经营现金流/净利润 | 0.84× | 3.19× |
| 过去12个月自由现金流最近4个季度 | $2.0B | $117.2M |
8季度趋势，按日历期对齐
经营现金流MNSTSEM
| Q4 25 | $379.4M | $64.3M | ||
| Q3 25 | $745.1M | $175.3M | ||
| Q2 25 | $466.0M | $110.3M | ||
| Q1 25 | $507.6M | $-3.5M | ||
| Q4 24 | $461.7M | $125.4M | ||
| Q3 24 | $618.4M | $181.0M | ||
| Q2 24 | $436.3M | $278.2M | ||
| Q1 24 | $412.1M | $-66.7M |
自由现金流MNSTSEM
| Q4 25 | $351.2M | $5.2M | ||
| Q3 25 | $701.5M | $122.2M | ||
| Q2 25 | $434.6M | $45.6M | ||
| Q1 25 | $478.5M | $-55.8M | ||
| Q4 24 | $370.4M | $62.0M | ||
| Q3 24 | $571.4M | $130.3M | ||
| Q2 24 | $376.5M | $222.6M | ||
| Q1 24 | $346.1M | $-119.2M |
自由现金流率MNSTSEM
| Q4 25 | 16.5% | 0.4% | ||
| Q3 25 | 31.9% | 9.0% | ||
| Q2 25 | 20.6% | 3.4% | ||
| Q1 25 | 25.8% | -4.1% | ||
| Q4 24 | 20.4% | 4.7% | ||
| Q3 24 | 30.4% | 10.2% | ||
| Q2 24 | 19.8% | 17.4% | ||
| Q1 24 | 18.2% | -9.0% |
资本支出强度MNSTSEM
| Q4 25 | 1.3% | 4.2% | ||
| Q3 25 | 2.0% | 3.9% | ||
| Q2 25 | 1.5% | 4.8% | ||
| Q1 25 | 1.6% | 3.9% | ||
| Q4 24 | 5.0% | 4.8% | ||
| Q3 24 | 2.5% | 4.0% | ||
| Q2 24 | 3.1% | 4.3% | ||
| Q1 24 | 3.5% | 4.0% |
现金转化率MNSTSEM
| Q4 25 | 0.84× | 3.19× | ||
| Q3 25 | 1.42× | 6.09× | ||
| Q2 25 | 0.95× | 2.72× | ||
| Q1 25 | 1.15× | -0.06× | ||
| Q4 24 | 1.71× | — | ||
| Q3 24 | 1.67× | 3.25× | ||
| Q2 24 | 1.03× | 3.59× | ||
| Q1 24 | 0.93× | -0.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MNST
| Monster Energy Drinks Segment | $1.2B | 57% |
| Sales Revenue Product Line | $905.5M | 42% |
| Strategic Brands Segment | $50.3M | 2% |
| Alcohol Brands Segment | $29.0M | 1% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
